home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  November 16, 2018
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 549 active entries

Gene Bridges GmbH

Im Neuenheimer Feld 584
Heidelberg, 69120
Germany

Phone: +49 (0)6221 1370 810
Fax: +49 (0)6221 1370 829
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Gene Bridges GmbH is a self-financed biotechnology company pioneering “recombineering”, a scientific approach that allows site-specific and size-independent cloning/DNA modification. The Company’s Red/ET™ Recombination technology is a patent-protected recombineering technology that enables researchers the freedom to design and experiment in transgenics, E.coli chromosome modification and many other areas of genetic modification.

Commercial licenses are readily available to use the technology and Gene Bridges provides recombineering services and also ready-to-use recombineering kits for academic research. The Company is privately held and was founded in 2000 as spin-off from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany. Further information on Gene Bridges can be found at www.genebridges.com

 

 



Selected Categories:
Product Company   Service Company
Biotech
- General
Supplier
- Research
Contract
- Research
- Services

Last update of this entry: September 27, 2017

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.